Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Sep 01, 2026
ARK Innovation ETF (ARKK) Advances +13% Over the Past 30 Days

ARK Innovation ETF (ARKK) Advances +13% Over the Past 30 Days

Key Takeaways

  • ARKK advanced roughly +13% over the last 30 days, rebounding from a late-July low near $70 to the mid-$80s.
  • The fund has also gained about +12% over the last quarter, extending a broader recovery in high-growth equities.
  • As an actively managed, concentrated "disruptive innovation" portfolio, ARKK amplifies swings in growth, biotechnology, and digital-asset sentiment.
  • Tesla, its largest holding, plus crypto-linked financials such as Coinbase, Robinhood, and Circle, and genomics leaders like CRISPR Therapeutics and Tempus AI were central to the move.
  • With a 0.75% expense ratio and roughly 45 holdings, ARKK remains a high-beta, non-diversified thematic vehicle.

ARK Innovation ETF (ARKK) Overview and Portfolio Exposure

ARK Innovation ETF is an actively managed exchange-traded fund sponsored by ARK Invest. It seeks long-term growth of capital by investing primarily in domestic and foreign equities tied to the theme of disruptive innovation, spanning genomics, next-generation internet, artificial intelligence, digital assets, and industrial innovation. The fund is non-diversified and typically holds roughly 40 to 50 positions, with a 0.75% net expense ratio and assets under management of approximately $6.5 billion to $7 billion.

The portfolio is concentrated in a handful of high-conviction names. TSLA (Tesla) is the largest single position, historically representing roughly 10% of assets. Other top holdings include TEM (Tempus AI), CRSP (CRISPR Therapeutics), ROKU (Roku), SHOP (Shopify), COIN (Coinbase), HOOD (Robinhood), AMD (Advanced Micro Devices), Circle Internet Group, and RBLX (Roblox). By sector, the fund's largest exposures are healthcare (roughly 28–30%), information technology (roughly 24–26%), financial services (roughly 15%), consumer cyclical (roughly 13–15%), communication services (roughly 10–12%), and industrials (roughly 5%).

This structure helps explain recent behavior: because a small number of large, high-beta growth and digital-asset-linked names dominate the portfolio, ARKK tends to move sharply whenever risk appetite shifts across the innovation complex. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

ARK Innovation ETF (ARKK) Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, ARKK advanced approximately +13%, from a closing level near $76 in late July to the mid-$80s. The move was not linear: the fund first drifted lower into late July, dipping toward $70, before staging a sustained, trend-driven recovery through August with gains building across consecutive weeks.

The quarterly picture is similar. From a mid-May closing level near $76.50, ARKK rose roughly +12% to the mid-$80s. That three-month gain reflects a broader rebound in growth and innovation-oriented equities after an earlier stretch of pressure, and it underscores the fund's tendency to deliver outsized moves in both directions during shifts in risk sentiment.

What Drove ARKK Price in the Last 30 Days

The 30-day advance was driven primarily by the fund's largest, highest-beta positions. TSLA, which carries the largest single weight in the portfolio, was a key contributor. Crypto-linked financials—COIN, HOOD, and Circle Internet Group—also played an outsized role, reflecting improved sentiment across the digital-asset ecosystem. In biotechnology and genomics, positions such as CRSP and TEM contributed to the healthcare-heavy tilt of the portfolio.

More broadly, the move coincided with a recovery in risk appetite for growth and disruptive-technology equities, which had pulled back sharply in late July. Because ARKK is non-diversified and heavily concentrated in these themes, the same dynamics that pressured the fund into its late-July low also powered the subsequent rebound. Interest-rate expectations and investor positioning across long-duration, high-multiple growth assets were central factors, since such names are especially sensitive to shifts in the discount-rate environment.

What Drove ARKK Performance Over the Last Quarter

Over the last quarter, ARKK's roughly +12% advance reflected a broader sector rotation back toward growth and innovation themes after an earlier bout of volatility. The fund's largest positions—led by Tesla, crypto-linked financials, and genomics names—recovered from their mid-year troughs, and the portfolio's concentration in these segments amplified the upside. Institutional and retail flows into thematic growth ETFs remained an important backdrop, as did the ongoing debate over the pace of monetary policy and its effect on high-multiple, longer-duration equities. The quarter's trend illustrates ARKK's structural character: a high-conviction, concentrated strategy that tends to lead in risk-on environments and lag when defensive positioning dominates.

ARKK ETF Outlook: What Investors Should Watch Next

Looking ahead, the key variables for ARKK are the same forces that have driven its recent swings. Interest-rate expectations and inflation data will remain central, given the portfolio's heavy weighting in long-duration, high-multiple growth assets. The earnings trajectory of its largest holdings—Tesla, crypto-linked financials, and genomics companies—will also matter, as will the health of the artificial-intelligence and digital-asset investment themes that anchor much of the portfolio. Sector rotation, capital flows into thematic ETFs, and any regulatory developments affecting digital assets or biotechnology could all influence the fund's path. Because ARKK is non-diversified and concentrated, investors should expect continued volatility in both directions, with performance likely to remain closely tied to shifts in overall risk appetite.

Using Tickeron’s AI Tools in My Research

In my research process, I often turn to Tickeron's AI Screener to quickly scan for holdings and compare performance metrics across similar thematic ETFs. It helps filter for momentum and volatility factors that matter most when evaluating funds like ARKK, allowing me to isolate the individual names and sectors driving recent moves more efficiently.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ARKK

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


Momentum Indicator for ARKK turns positive, indicating new upward trend

ARKK saw its Momentum Indicator move above the 0 level on September 16, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned positive. In 83 of the 88 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for ARKK crossed bullishly above the 50-day moving average on August 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.

Following a +6.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARKK advanced for three days, in 272 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

The Aroon Indicator entered an Uptrend today. In 206 of 241 cases where ARKK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.

Bearish Trend Analysis

The 10-day RSI Indicator for ARKK moved out of overbought territory on August 24, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 30 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for ARKK turned negative on September 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 50 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARKK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

Notable companies

The most notable companies in this group are Amazon.com (NASDAQ:AMZN), Meta Platforms (NASDAQ:META), Tesla (NASDAQ:TSLA), Advanced Micro Devices (NASDAQ:AMD), Deere & Company (NYSE:DE), Shopify Inc (NASDAQ:SHOP), Teradyne (NASDAQ:TER), Block Inc (NYSE:XYZ), Illumina (NASDAQ:ILMN), Roku (NASDAQ:ROKU).

Industry description

The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund's investment theme of disruptive innovation. Its investments in foreign equity securities will be in both developed and emerging markets. The fund may invest in foreign securities listed on foreign exchanges as well as American Depositary Receipts (“ADRs”) and Global Depositary Receipts (“GDRs”). The fund is non-diversified.

Market Cap

The average market capitalization across the ARK Innovation ETF (ARKK) ETF is 212.26B. The market cap for tickers in the group ranges from 425.84M to 2.74T. AMZN holds the highest valuation in this group at 2.74T. The lowest valued company is PACB at 425.84M.

High and low price notable news

The average weekly price growth across all stocks in the ARK Innovation ETF (ARKK) ETF was 6%. For the same ETF, the average monthly price growth was 6%, and the average quarterly price growth was 28%. TEM experienced the highest price growth at 32%, while DKNG experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the ARK Innovation ETF (ARKK) ETF was 133%. For the same stocks of the ETF, the average monthly volume growth was 39% and the average quarterly volume growth was -18%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 65
Price Growth Rating: 47
SMR Rating: 71
Profit Risk Rating: 82
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
ARKK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category MidCapGrowth

Profile
Details
Category
Mid-Cap Growth
Address
ARK ETF Trust155 West 19th Street, 5th FloorNew York
Phone
212-426-7040
Web
www.ark-funds.com
Interact to see
Advertisement
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.
Shares of KC surged approximately +17% in premarket trading on March 18, 2026, from a prior close of $13.12 to approximately $15.35. The primary catalyst is Kingsoft Cloud's release of its unaudited Q4 and full-year 2025 financial results before the U.S. market open, which appear to have significantly exceeded analyst expectations.
AngloGold Ashanti (AU) shares tumbled approximately 7% in premarket trading on March 18, 2026, extending a multi-week downtrend that has erased nearly 20% of the stock's value since late January highs. The primary catalyst driving the decline is persistent investor concern over AngloGold's lowered 2026 production guidance, with the company projecting gold output of 2.80–3.17 million ounces — a roughly 3% decline from its 2025 production of 3.1 million ounces.
AAOI shares surged approximately 10.90% in premarket trading on March 18, 2026, rising from a prior close of $86.33 to $95.74. The primary catalyst is strong positive sentiment generated at OFC 2026 — the Optical Fiber Communications Conference and Exhibition — where Applied Optoelectronics unveiled breakthrough laser and transceiver technology for next-generation AI data center infrastructure.
LITE shares surged approximately +12% in early Wednesday trading on March 18, 2026, with the stock changing hands near $727 compared to a prior session close of $649.56. The primary near-term catalyst is Lumentum's S&P 500 index inclusion, effective March 23, 2026, triggering front-running by institutional investors and mandatory buying by passive index funds.
Shares of New Era Energy & Digital, Inc. (NUAI) are trading down approximately 17% during today's session, with the prior close sitting at $5.56. The decline follows the company's March 17 business update conference call and webcast, held after market hours, during which management discussed the recently filed fiscal year 2025 annual report (Form 10-K).
Shares of Regencell Bioscience Holdings (RGC) are up approximately +16% intraday on March 18, 2026, trading at $26.56 against a prior close of $22.97. No single company-specific press release is driving today's move; the rally is primarily fueled by retail-driven momentum and short squeeze mechanics.
A jump in the Producer Price Index from 0.3% to around 0.7% month‑over‑month signals that wholesale inflation is re‑accelerating, delaying Fed rate‑cut hopes and reviving the “higher for longer” rates narrative.business. Likely winners in this environment include energy and commodity producers (XOM, CVX, TTE, COP), inflation‑resilient financials (JPM, BAC), and real‑asset plays like pipelines and infrastructure, which can pass through higher prices; ETFs like XLE, XOP, XLF, DBA, GLD offer diversified exposure.
BGSI fell more than 11% today, pulling back from recent levels around the high‑$150s as investors reassessed the risk‑reward following the Q4 2025 print and major U.S. expansion plans. Full‑year 2025 sales rose 2.4% to US$3.14 billion, but same‑store sales declined 0.2%, while reported net earnings fell 25% to US$18.4 million due to US$22.6 million in acquisition and transformation costs.